These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 34298989)

  • 1. Mitochondrial Heteroplasmy Shifting as a Potential Biomarker of Cancer Progression.
    Pérez-Amado CJ; Bazan-Cordoba A; Hidalgo-Miranda A; Jiménez-Morales S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Manipulation of mtDNA Heteroplasmy: A Shifting Perspective.
    Jackson CB; Turnbull DM; Minczuk M; Gammage PA
    Trends Mol Med; 2020 Jul; 26(7):698-709. PubMed ID: 32589937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mitochondrial DNA variants at low level heteroplasmy in pediatric CNS and extra-CNS solid tumors with three different enrichment methods.
    Kaneva K; Merkurjev D; Ostrow D; Ryutov A; Triska P; Stachelek K; Cobrinik D; Biegel JA; Gai X
    Mitochondrion; 2020 Mar; 51():97-103. PubMed ID: 31972374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heteroplasmy Shifting as Therapy for Mitochondrial Disorders.
    Naeem MM; Sondheimer N
    Adv Exp Med Biol; 2019; 1158():257-267. PubMed ID: 31452145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-editing enzymes as potential treatments for heteroplasmic mtDNA diseases.
    Zekonyte U; Bacman SR; Moraes CT
    J Intern Med; 2020 Jun; 287(6):685-697. PubMed ID: 32176378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual mtDNA Control Region Length Heteroplasmy in the COS-7 Cell Line.
    Kozhukhar N; Mitta S; Alexeyev MF
    Genes (Basel); 2020 May; 11(6):. PubMed ID: 32486194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders.
    Stefano GB; Kream RM
    Cell Mol Neurobiol; 2022 Jan; 42(1):99-107. PubMed ID: 34117968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial DNA copy number changes, heteroplasmy, and mutations in plasma-derived exosomes and brain tissue of glioblastoma patients.
    Soltész B; Pös O; Wlachovska Z; Budis J; Hekel R; Strieskova L; Liptak JB; Krampl W; Styk J; Németh N; Keserű JS; Jenei A; Buglyó G; Klekner Á; Nagy B; Szemes T
    Mol Cell Probes; 2022 Dec; 66():101875. PubMed ID: 36379303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial DNA heteroplasmy in disease and targeted nuclease-based therapeutic approaches.
    Nissanka N; Moraes CT
    EMBO Rep; 2020 Mar; 21(3):e49612. PubMed ID: 32073748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial DNA: Inherent Complexities Relevant to Genetic Analyses.
    Ferreira T; Rodriguez S
    Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial genome analysis in penile carcinoma.
    Araujo LF; Terra AT; Sares CTG; Sobreira CFR; Faria EF; Machado RD; Rodrigues AA; Muglia VF; Silva WA; Reis RB
    Mol Biol Rep; 2018 Aug; 45(4):591-600. PubMed ID: 29948632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell mtDNA heteroplasmy in colorectal cancer.
    Almeida J; Pérez-Figueroa A; Alves JM; Valecha M; Prado-López S; Alvariño P; Cameselle-Teijeiro JM; Chantada D; Fonseca MM; Posada D
    Genomics; 2022 Mar; 114(2):110315. PubMed ID: 35181467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA Mutation Analysis in Breast Cancer: Shifting From Germline Heteroplasmy Toward Homoplasmy in Tumors.
    Pérez-Amado CJ; Tovar H; Gómez-Romero L; Beltrán-Anaya FO; Bautista-Piña V; Dominguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Alfaro-Ruíz LA; Hidalgo-Miranda A; Jiménez-Morales S
    Front Oncol; 2020; 10():572954. PubMed ID: 33194675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Mitochondria DNA Mutations in Diseases.
    Zhu Z; Wang X
    Adv Exp Med Biol; 2017; 1038():219-230. PubMed ID: 29178079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing Low-Level mtDNA Heteroplasmy-Pitfalls and Challenges from Bench to Benchmarking.
    Fazzini F; Fendt L; Schönherr S; Forer L; Schöpf B; Streiter G; Losso JL; Kloss-Brandstätter A; Kronenberg F; Weissensteiner H
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a 'differential multiple cleavage-site' model.
    Bacman SR; Williams SL; Hernandez D; Moraes CT
    Gene Ther; 2007 Sep; 14(18):1309-18. PubMed ID: 17597792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of mitochondrial DNA heteroplasmy detection using Next Generation Sequencing.
    González MDM; Ramos A; Aluja MP; Santos C
    Mitochondrion; 2020 Jan; 50():88-93. PubMed ID: 31669622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease.
    Bayona-Bafaluy MP; Blits B; Battersby BJ; Shoubridge EA; Moraes CT
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14392-7. PubMed ID: 16179392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulation of mitochondrial genes and mtDNA heteroplasmy.
    Bacman SR; Gammage PA; Minczuk M; Moraes CT
    Methods Cell Biol; 2020; 155():441-487. PubMed ID: 32183972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances Towards Therapeutic Approaches for mtDNA Disease.
    Al Khatib I; Shutt TE
    Adv Exp Med Biol; 2019; 1158():217-246. PubMed ID: 31452143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.